Development of a treatment for the durable remission of HIV using autologous human car t cells that target b cell follicles
Ended Project Grant Awarded Last action
- Award ID
- R41AI155031
- Recipient
-
Marpam Pharma LLC UEI FJN8ZEF912K7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $456,000
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $404,000.00 Federal
- $52,000.00 Non-federal
- Place of performance
- Minnesota, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $52,000 | $0 | |
| Amendment | $52,000 | $52,000 | |
| Original award | $300,000 | $0 |
Quick answers
Who received award R41AI155031?
R41AI155031 was awarded to Marpam Pharma LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 18, 2020.
How much is award R41AI155031 worth?
$456,000 has been obligated on R41AI155031: $404,000 in federal funding and $52,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award